CHEERS to Patient Engagement

It’s Time for Patients to Drive Healthcare Research When the new CHEERS report was released, we were pleased to see the updated standards regarding patient and stakeholder engagement. These standards reflect a growing recognition that patient and stakeholder engagement need to be incorporated into economic evaluations and healthcare research from the conceptualization stage rather than […]

Health Care Value Through The Lens Of Patients’ Well-Being

In the concluding IVI and Health Affairs Forefront series post, Jennifer Bright and National Patient Advocate Foundation’s Alan Balch write if we are to overcome inertia and truly transform to a value-based healthcare system, we must establish: A shared commitment to patient needs, experiences, and perspectives as key drivers in measuring value; Clarity around exactly […]

Value Assessment And Decision Making In The Face Of Uncertainty

In the penultimate Health Affairs Forefront series, Mark Linthicum, Richard Chapman, and Jeroen Jansen address uncertainty in healthcare value assessment and decision-making and identify the following opportunities for change: We need a more dynamic approach to value assessment. Economic models should include both parameter and structural uncertainty to fully characterize the implications for decision-making. Gaps […]

Frequently Asked Questions about the IVI Draft Protocol for Major Depressive Disorder

Introduction The Innovation and Value Initiative welcomes public comments on its draft model protocol on major depressive disorder. The deadline to submit comments has been extended to Tuesday, January 25th. This economic model currently under development is part of IVI’s Open-Source Value Project (OSVP). You can learn more about the model protocol through IVI’s introductory […]

Value In Medicaid, Part 2: Challenges Concerning Health-Related Social Needs

In the second of a two-part Health Affairs post, Dr. Anish Mahajan writes about several challenges concerning health-related social needs in the journey to value in Medicaid. He addresses challenges including use of social needs screening tools, case management infrastructure and workflow development. He also cites the need for further research to better align the health and social sectors […]

Value In Medicaid, Part 1: Administrative, Regulatory, And Financial Challenges

Part 1 in a two-part blog series by Anish P. Mahajan, MD, the Chief Executive Officer of Harbor-UCLA Medical Center and Associate Dean at UCLA-Geffen School of Medicine, examines the administrative, regulatory, and financial challenges to achieving value in the Medicaid program. Read the full article here. About the Blog Series The Innovation and Value […]

Pursuing Health Care Value Post-COVID-19: Keep The Focus On Patients

At the midpoint of the Health Affairs and IVI blog series, PCORI’s Nakela Cook discusses an essential lesson from the pandemic that must be applied to clinical research, healthcare delivery, and public health – patients must help drive the calculus that policymakers apply to building a more equitable, affordable healthcare system that delivers optimal outcomes. […]

How Current Cost-Effectiveness Analyses Distort Drug Development Priorities

In the latest post in our ongoing series with Health Affairs blog, Soeren Mattke takes on the relationship value assessment and innovation of new therapies. He argues that cost-effectiveness analysis, one of the most common methods for economic assessments, may be distorting the incentives for investment in medical research and drug development. Specifically, he explains […]

IVI MEMBER SPOTLIGHT: Danny van Leeuwen

This year we are pleased to welcome Danny van Leeuwen as a new member of the Innovation and Value Initiative. Danny is the host of HealthHats, a podcast and blog that helps people learn on the journey towards health. We were delighted that he took the time to speak with our own Jennifer Bright on […]